Magnesium Level in the Mortality Prediction of Community-acquired Pneumonia Patients

被引:0
|
作者
Acar, Ethem [1 ]
Gokcen, Hasan [1 ]
Demir, Ahmet [1 ]
Yildirim, Birdal [1 ]
机构
[1] Mugla Sitki Kocman Univ, Fac Med, Dept Emergency Med, Mugla, Turkey
来源
MEANDROS MEDICAL AND DENTAL JOURNAL | 2022年 / 23卷 / 02期
关键词
Community-acquired pneumonia; magnesium level; mortality; emergency medicine; SERUM;
D O I
10.4274/meandros.galenos.2021.47855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aimed to examine the contribution of pneumonia severity index and blood magnesium (Mg) level of community-acquired pneumonia (CAP) patients who received inpatient treatment in our hospital to the mortality of the cases. Materials and Methods: Our study is a retrospective study in which we applied to the emergency department (ED) of our hospital in 2018, with the diagnosis of CAP, and were hospitalized to the wards or intensive care unit (ICU). Results: A total of 279 patients with CAP were enrolled in this study. All-cause mortality on the 28th day of follow-up was 13.6%. There were statistically significant results between the 2 groups (survivors and non-survivors), which were classified based on their 28-day mortality rates, in terms of the Mg, pneumonia severity index (PSI), and confusion, urea, respiratory rate, blood pressure, age >65 years (CURB-65) values. Moreover, the optimal Mg cut-off for predicting 28-day mortality at the time of ED admission was determined to be 1.90 mg/dL, with 71% sensitivity, 73% specificity, and 73% accuracy. ROC analysis revealed that the areas of Mg under the AUC in terms of 28-day mortality were 0.778. Thirty-eight patients died during the first 28-day period. Of these, 27 (64,2 0 10) had Mg level <1.90 mg/dL. Independent predictors of 28-day mortality rates were determined to be Mg (lower than 1.90 mg/dL), CURB-65, PSI, vasopressor need and stay ICU. Conclusion: Mortality rates increase as the Mg level decreases in CAP patients.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [41] The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
    Miteva, Darina
    Radkov, Yordan
    Kostadinova, Vanya
    Dyakova, Anna
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Early mortality in patients with community-acquired pneumonia:: causes and risk factors
    Garcia-Vidal, C.
    Fernandez-Sabe, N.
    Carratala, J.
    Diaz, V.
    Verdaguer, R.
    Dorca, J.
    Manresa, F.
    Gudiol, F.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (03) : 733 - 739
  • [43] Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia
    Peyrani, Paula
    Ramirez, Julio
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (05): : 421 - 421
  • [44] Mortality in COPD patients with community-acquired pneumonia:: who is the third partner?
    Torres, A.
    Menendez, R.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (02) : 262 - 263
  • [45] Community-acquired Pneumonia - Common for the Patients
    Bauer, T. T.
    Lorenz, J.
    PNEUMOLOGE, 2015, 12 (02): : 99 - 100
  • [46] Community-acquired pneumonia in elderly patients
    Niederman, MS
    Ahmed, QAA
    CLINICS IN GERIATRIC MEDICINE, 2003, 19 (01) : 101 - +
  • [47] Community-acquired pneumonia in patients with HIV
    Cunha, BA
    DRUGS OF TODAY, 1998, 34 (09): : 739 - 745
  • [48] Hospitalization of patients with community-acquired pneumonia
    Ordóñez, MAG
    González, BP
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (05): : 240 - 241
  • [49] Predictors of mortality in lung cancer patients hospitalized with community-acquired pneumonia
    Kara, Kaan
    Cavdar, Eyyup
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (05): : 318 - 323
  • [50] PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia
    Rubulotta, F.
    Ramsay, D.
    Williams, Mark D.
    CRITICAL CARE MEDICINE, 2010, 38 (04) : 1236 - 1236